With recent declines in jobless claims and upward GDP revisions, markets remain uncertain about the pace of upcoming Fed rate cuts. Meanwhile, new tariffs announced by President Trump on pharmaceuticals and other goods are stirring volatility in global markets, particularly hitting major pharmaceuti

AI-generated source summary

The analysis discusses several financial instruments and their potential movements based on news and economic data. Dow futures rose by 73 points, while S&P 500 and NASDAQ 100 futures edged up slightly. J.Beelle shares fell due to analyst concerns. Tariffs on branded pharmaceuticals are set to take effect from October 1, and this is expected to affect European and Asian pharmaceutical companies. Furthermore, the United States government is considering policies to reduce reliance on semiconductor imports, which may affect global chipmakers. The core personal consumption expenditures inflation rate is expected to remain steady. Gold prices steadied after retreating from record highs. There is a cautious outlook regarding future Federal Reserve rate cuts, with markets assigning an 88% probability to a 25 basis point rate cut in October.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   26 Sept 2025, 13:17 UTC

   The analyst published the original source item.

2. First prediction resolved

   29 Sept 2025, 13:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

4. Market predictions extracted

   18 May 2026, 20:47 UTC

   3 eligible signals linked to this case.

5. Outcome tracking started

   02 Jul 2026, 01:22 UTC

   Tahlil Plus began monitoring the extracted predictions.

6. Case evaluation completed

   18 Jul 2026, 13:34 UTC

   All evaluable predictions in this case reached terminal outcomes.